Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
HIV Clinical Trials|October 9, 2001
Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimensM Duong, L Piroth, M Grappin, et al.Presse Medicale (Paris, France : 1983)|May 22, 2001
[Indinavir-ritonavir combination: pharmacologic results and tolerance in patients infected by HIV]F Bani-Sadr, P Perré, G Peytavin, et al.HIV Clinical Trials|December 17, 2013
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patientsS Abgrall, J Le Bel, N Lele, et al.Antimicrobial Agents and Chemotherapy|February 25, 2005
Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia modelE Azoulay-Dupuis, J P Bédos, J Mohler, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic responseM Duong, L Piroth, G Peytavin, et al.The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese miceI Gaou, M Malliti, M C Guimont, et al.European Journal of Clinical Pharmacology|May 13, 2005
Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteersG Peytavin, C Gautran, C Otoul, et al.New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.HIV Clinical Trials|October 24, 2001
Randomized salvage therapy with saquinavir-ritonavir versus saquinavir-nelfinavir for highly protease inhibitor-experienced HIV-infected patientsP Chavanet, L Piroth, M Grappin, et al.Pageof 8